Ishihara Sangyo Kaisha, Ltd.

Jtekt Corporation

Oiles Corporation

Koyo Seiko Company, Ltd.

Bridgestone Kbg Co., Ltd

Kazuhiro Yamamoto

Hirohiko Kimura

Fuminori Kato

Takahiro Haga

Hideo Sugi

Itaru Shigehara

Shinji Odawara

Syuichi Yotsuya

Takashi Okada

Toru Koyanagi

Masahiko Hirose

Tetsuo Yoneda

Shigehisa Kanbayashi

Toyoshi Tanimura

Masao Shimura

Katsutoshi Nishimura

Yoshiro Kuzumi

Keizo Miyata

Tatsunori Yoshida

Hiroyuki Ikegami

Hiromi Takeo

Yohei Taguchi

Kazuyoshi Iida

Masayuki Morita

Tadaaki Toki

Fumio Kanamori

Takahiro Tanaka

Kiyomitsu Yoshida

Masaaki Hashimoto

Mitsuo Sano

Masato Omatsu

Masayuki Sekine

Shunji Yuki

Toshihiko Ueki

Kiyoshi Tamai

Ryuji Miyamoto

Koji Sakata

Takanori Kato

Kumiko Azuma

Tetsuya Murashima

Shinya Mori

A motor includes a motor housing, a motor body, and a damping member. The motor body includes a drive shaft. The motor body is housed in the motor housing. The damping member is disposed on an outer surface of the motor housing. The damping member includes a damping layer and a constraining layer. The damping layer is made of an organic polymeric material, and bonded to the outer surface of the motor housing. The constraining layer is made of at least one of a resin mixed with an inorganic compound and an elastomer mixed with an inorganic compound. The constraining layer is disposed on the damping layer.

Motor having a damping member disposed on a motor housing

To provide a process for producing an anthranilamide having the 3-position of pyrazole substituted by a bromine atom, or its salt. A process for producing an anthranilamide compound represented by the formula (I) or its salt:   

Process for producing anthranilamide compound

To provide a process for producing a specific anthranilamide compound or its salt. To provide a process for producing an anthranilamide compound represented by the formula (I) or its salt: wherein each of Rand Rwhich are independent of each other, is halogen or haloalkyl; Ris cyclopropyl alkyl or cyclobutyl alkyl; and Hal is a chlorine atom or a bromine atom, which comprises a step of selectively halogenating a compound represented by the formula (II): wherein R, Rand Rare as defined above.

A method of manufacturing a rack guide base body wherein a cavity () is formed which has a pair of semicylindrical convex surfaces (and) and a pair of flat surfaces () each located between the semicylindrical convex surfaces (and), and has a recessed surface () located on one axial end portion side inwardly of the semicylindrical convex surfaces (and) and the flat surfaces () and a cylindrical surface () located on the other axial end portion side inwardly of the semicylindrical convex surfaces (and) and the flat surfaces (); a hollow portion () is formed for allowing the cavity () to communicate with a hollow portion () at one flat surface () and with a hollow portion () at the other flat surface (); a rack guide base body () is die cast by forcing molten metal of aluminum from the hollow portion () into the cavity (); and runners () integrally joined to flat surfaces () of the rack guide base body () formed by the respective flat surfaces () are cut off.

Method of manufacturing rack guide base body in rack-and-pinion type steering apparatus and rack guide

To provide cytokine production inhibitors useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions. A cytokine production inhibitor containing, as an active ingredient, a thioamide compound represented by the formula (I) or a salt thereof: wherein A is N, NO, C&#x2014;NOor C&#x2014;CN; Hal is a halogen; Mis alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heterocyclyl, amino, O, S, SO or SO; Mis amino, O, S or a single bond; Ris a halogen, alkyl or the like; each of R, R, Rand Ris independently H, alkyl or the like; Ris a halogen, alkyl or the like; Cy is cycloalkyl, cycloalkenyl, aryl or heterocyclyl; each of k, p and q is independently an integer of from 0 to 3; and r is an integer of from 0 to 5.

Thioamides and salts thereof and cytokine production inhibitors containing both

A rack guide includes a rack guide base body which has on its outer peripheral surface a pair of semicylindrical surfaces and a pair of planar surfaces each located between the pair of semicylindrical surfaces, has a concavely recessed surface located on one axial end portion side inwardly of the pair of semicylindrical surfaces and the planar surfaces, and has a cylindrical surface located on the other axial end portion side inwardly of the pair of semicylindrical surfaces and the planar surfaces; and a slider secured to the rack guide base body.

Method of production rack guide base body in rack-and-pinion type steering device and rack guide

The present invention provides a cytokine production inhibitor containing as an active ingredient an aniline derivative of the formula (I) or a salt thereof: [wherein A is CO or SO; Cy is an aryl group or a heterocyclic group; each of Rand Rwhich are independent of each other, is a halogen atom, a cyano group, a nitro group, an alkyl group which may be substituted, an alkenyl group which may be substituted, an alkynyl group which may be substituted, a cycloalkyl group which may be substituted, a cycloalkenyl group which may be substituted, an aryl group which may be substituted, a heterocyclic group which may be substituted, an amino group which may be substituted or a &#x2014;B-Q group; Ris a -M-M-Rgroup; Ris a hydrogen atom or an alkyl group which may be substituted; x is an integer of from 0 to 5; y is an integer of from 0 to 4; and z is an integer of from 0 to 1].

Aniline derivatives or salts thereof and cytokine production inhibitors containing the same

The present invention provides a preventive or therapeutic medicine for diabetes containing as an active ingredient a fused-heterocyclic compound of the formula (I') or its salt: [wherein G is CN, NO, COR, CHO, SONRRor CONRR; Ris a halogen atom, a &#x2014;O&#x2014;Rgroup or a &#x2014;S&#x2014;Rgroup; Ris a halogen atom, a &#x2014;O&#x2014;Rgroup (wherein Ris as defined above) or an amino group which may be substituted; and each of Rand Rwhich are independent of each other, is a hydrogen atom, a halogen atom or an alkyl group].

Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts

Medical composition containing nitroetheneamine Derivative or salt there of as active constituent

Medical composition containing nitroetheneamine derivative or salt thereof as active constituent

A method of treating rheumatoid arthritis using a diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: ##STR1## wherein X is --CW.sup.1 R.sup.1, --COCOR.sup.2, --CW.sup.1 NHCOR.sup.2, --C(.dbd.W.sup.1)W.sup.2 R.sup.3 or --CW.sup.1 N(R.sup.4)R.sup.5, and Y is alkyl, --CW.sup.3 R.sup.6, --COCOR.sup.7, --NHCOR.sup.7, --C(.dbd.W.sup.3)W.sup.4 R.sup.8, --(NH).sub.m SO.sub.2 R.sup.9, --(NH).sub.m SO.sub.2 OR.sup.10 or --(NH).sub.m SO.sub.2 N(R.sup.11)R.sup.12, wherein each of R.sup.1, R.sup.6 and R.sup.9, which are independent from one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted as further defined herein.

Diaminotrifluoromethylpyridine derivatives, process for their production

A diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: ##STR1## wherein X is --CW.sup.1 R.sup.1, --COCOR.sup.2, --CW.sup.1 NHCOR.sup.2, --C(.dbd.W.sup.1)W.sup.2 R.sup.3 or --CW.sup.1 N(R.sup.4)R.sup.5, and Y is alkyl, --CW.sup.3 R.sup.6, --COCOR.sup.7, --NHCOR.sup.7, --C(.dbd.W.sup.3)W.sup.4 R.sup.8, --(NH).sub.m SO.sub.2 R.sup.9, --(NH).sub.m SO.sub.2 OR.sup.10 or --(NH).sub.m SO.sub.2 N(R.sup.11)R.sup.12, as defined herein.

A hydrazine compound of the formula (I) or its salt: ##STR1## wherein A is a benzofuranyl group which may be substituted, a quinolinyl group which may be substituted, a benzothienyl group which may be substituted, a benzothiazolyl group which may be substituted, a thienothienyl group which may be substituted, a dihydrothienothienyl group which may be substituted, a dihydrocyclopentathienyl group which may substituted, a tetrahydrobenzothienyl group which may be substituted, an indanyl group which may be substituted, or a hexahydroindanyl group which may be substituted, W is a hydrogen atom, a cyano group, --COCOOR', --S--N(R')COOR' or --CH.sub.2 OCOR', wherein each of R' and R' which are independent from each other, is an alkyl group or a cycloalkyl group, R is a halogen atom, an alkyl group which may be substituted by a halogen atom, an alkoxy group which may substituted by a halogen atom, an alkylthio group which may be substituted by a halogen atom, or a nitro group, n is an integer of from 0 to 5, provided that when n is 2 or more, the plurality of R may be the same or different.

Hydrazine compounds usesful as pesticides

A diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: ##STR1## wherein X is --CW.sup.1 R.sup.1, --COCOR.sup.2, --CW.sup.1 NHCOR.sup.2, --C(.dbd.W.sup.1)W.sup.2 R.sup.3 or --CW.sup.1 N(R.sup.4)R.sup.5, and Y is alkyl, --CW.sup.3 R.sup.6, --COCOR.sup.7, --NHCOR.sup.7, --C(.dbd.W.sup.3)W.sup.4 R.sup.8, --(NH).sub.m SO.sub.2 R.sup.9, --(NH).sub.m SO.sub.2 OR.sup.10 or --(NH).sub.m SO.sub.2 N(R.sup.11)R.sup.12, wherein each of R.sup.1, R.sup.6 and R.sup.9, which are independent from one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted, each of R.sup.2 and R.sup.7, which are independent from each other, is alkyl which may be substituted, alkoxy which may be substituted, phenyl which may be substituted or phenoxy which may be substituted, each of R.sup.3, R.sup.8 and R.sup.10, which are independent from one another, is alkyl which may be substituted, alkenyl which may be substituted, alkynyl which may be substituted, cycloalkyl which may be substituted, phenyl which may be substituted or benzyl which may be substituted, each of R.sup.4, R.sup.5, R.sup.11 and R.sup.12, which are independent from one another, is alkyl which may be substituted, each of W.sup.1, W.sup.2, W.sup.3 and W.sup.4, which are independent from one another, is an oxygen atom or a sulfur atom, and m is 0 or 1, provided that a combination wherein one of X and Y is --COCF.sub.2 X.sup.1 wherein X.sup.1 is a hydrogen atom, a halogen atom, alkyl or haloalkyl, and the other is --COCF.sub.2 X.sup.2 wherein X.sup.2 is a hydrogen atom, a halogen atom, alkyl, haloalkyl or alkylcarbonyl, or --COOX.sup.3 wherein X.sup.3 is alkyl which may be substituted or phenyl which may be substituted, is excluded.

Diaminotrifluoromethylpyridine compounds and phospholipase A.sub.2

A diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: ##STR1## wherein X is --CW.sup.1 R.sup.1, --COCOR.sup.2, --CW.sup.1 NHCOR.sup.2, --C(.dbd.W.sup.1 (W.sup.2 W.sup.3 or --CW.sup.1 N(R.sup.4)R.sup.5, and Y is alkyl, --CW.sup.3 R.sup.6, --COCOR.sup.7, --NHCOR.sup.7, --C(.dbd.W.sup.3)W.sup.4 R.sup.8, --(NH).sub.m SO.sub.2 R.sup.9, --(NH).sub.m SO.sub.2 OR.sup.10 or --(NH).sub.m SO.sub.2 N R.sup.11)R.sup.12, wherein each of R.sup.1, R.sup.6 and R.sup.9, which are independent from one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted, each of R.sup.2 and R.sup.7, which are independent from each other, is alkyl which may be substituted, alkoxy which may be substituted, phenyl which may be substituted or phenoxy which may be substituted, each of R.sup.3, R.sup.8 and R.sup.10, which are independent from one another, is alkyl which may be substituted, alkenyl which may be substituted, alkynyl which may be substituted, cycloalkyl which may be substituted, phenyl which may be substituted or benzyl which may be substituted, each of R.sup.4, R.sup.5, R.sup.11 and R.sup.12, which are independent from one another, is alkyl which may be substituted, each of W.sup.1, W.sup.2, W.sup.3 and W.sup.4, which are independent from one another, is an oxygen atom or a sulfur atom, and m is 0 or 1, provided that a combination wherein one of X and Y is --COCF.sub.2 X.sup.1 wherein X.sup.1 is a hydrogen atom, a halogen atom, alkyl or haloalkyl, and the other is --COCF.sub.2 X.sup.2 wherein X.sub.2 is a hydrogen atom, a halogen atom, alkyl, haloalkyl or alkylcarbonyl, or --COOX.sup.3 wherein X.sup.3 is alkyl which may be substituted or phenyl which may be substituted, is excluded.

Diaminotrifluoromethylpyridine derivatives and phospholipase A.sub.2

Growing community of inventors

Shiga, Japan

Kazuhiro Yamamoto